Related Experiment Video
Updated: Jun 28, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
A novel role of Shc adaptor proteins in steroid hormone-regulated cancers
Syed Mahfuzul Alam1, Mythilypriya Rajendran, Shouqiang Ouyang
1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska 68198-5870, USA.
Abstract:
Tyrosine phosphorylation plays a critical role in growth regulation, and its aberrant regulation can be involved in carcinogenesis. The association of Shc (Src homolog and collagen homolog) adaptor protein family members in tyrosine phosphorylation signaling pathway is well recognized. Shc adaptor proteins transmit activated tyrosine phosphorylation signaling that suggest their plausible role in growth regulation including carcinogenesis and metastasis. In parallel, by sharing a similar mechanism of carcinogenesis, the steroids are involved in the early stage of carcinogenesis as well as the regulation of cancer progression and metastatic processes. Recent evidence indicates a cross-talk between tyrosine phosphorylation signaling and steroid hormone action in epithelial cells, including prostate and breast cancer cells. Therefore, the members of Shc proteins may function as mediators between tyrosine phosphorylation and steroid signaling in steroid-regulated cell proliferation and carcinogenesis. In this communication, we discuss the novel roles of Shc proteins, specifically p52(Shc) and p66(Shc), in steroid hormone-regulated cancers and a novel molecular mechanism by which redox signaling induced by p66(Shc) mediates steroid action via a non-genomic pathway. The p66(Shc) protein may serve as an effective biomarker for predicting cancer prognosis as well as a useful target for treatment.
Insights
Shc proteins link tyrosine phosphorylation and steroid signaling in cancer. The p66(Shc) protein mediates steroid action through redox signaling, offering a potential biomarker and therapeutic target for cancer prognosis.
Area of Science:
- Molecular biology
- Cell signaling
- Cancer research
Background:
- Tyrosine phosphorylation is crucial for cell growth and its dysregulation contributes to cancer.
- Shc (Src homolog and collagen homolog) adaptor proteins are key players in tyrosine phosphorylation signaling pathways.
- Steroids are implicated in carcinogenesis and cancer progression, with recent evidence suggesting crosstalk with tyrosine phosphorylation signaling.
Purpose of the Study:
- To explore the role of Shc proteins, specifically p52(Shc) and p66(Shc), in steroid hormone-regulated cancers.
- To elucidate a novel molecular mechanism involving p66(Shc)-induced redox signaling in mediating steroid action via a non-genomic pathway.
Main Methods:
- The study discusses the established roles of Shc proteins in signaling pathways.
- It reviews recent evidence on the crosstalk between tyrosine phosphorylation and steroid hormone action.
- Focuses on the molecular mechanism of p66(Shc)-mediated steroid action.
Main Results:
- Shc proteins may act as mediators between tyrosine phosphorylation and steroid signaling in cell proliferation and carcinogenesis.
- A novel mechanism reveals that p66(Shc)-induced redox signaling mediates steroid action through a non-genomic pathway.
- p66(Shc) shows potential as a biomarker for cancer prognosis and a therapeutic target.
Conclusions:
- Shc proteins, particularly p52(Shc) and p66(Shc), play significant roles in steroid hormone-regulated cancers.
- The p66(Shc) protein mediates steroid action via non-genomic redox signaling, presenting a novel therapeutic avenue.
- p66(Shc) could serve as a valuable biomarker for predicting cancer outcomes and guiding treatment strategies.
Related Concept Videos
Hedgehog Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...

